Mécanismes moléculaires impliqués en aval du récepteur de l’hormone de croissance
-
Published:2012
Issue:
Volume:
Page:15-25
-
ISSN:
-
Container-title:Aspects biologiques, moléculaires et cliniques de l’axe GH/IGF-I
-
language:
-
Short-container-title:
Author:
Edouard T.,Salles J. P.
Reference48 articles.
1. Kaplan SA, Cohen P (2007) The somatomedin hypothesis 2007: 50 years later. J Clin Endocrinol Metab 92: 4529–35
2. Laron Z, Pertzelan A, Mannheimer S (1966) Genetic pituitary dwarfism with high serum concentation of growth hormone-a new inborn error of metabolism? Isr J Med Sci 2:152–5
3. Godowski PJ, Leung DW, Meacham LR et al. (1989) Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 86: 8083–7
4. Kelly PA, Djiane J, Postel-Vinay MC, Edery M (1991) The prolactin/growth hormone receptor family. Endocr Rev 12: 235–51
5. Salles JP, De Vries CP, Netelenbos JC, Slootweg MC (1994) Dexamethasone increases and serum decreases growth hormone receptor binding to UMR-106.01 rat osteosarcoma cells. Endocrinology 134: 1455–9